Perspective Therapeutics (CATX) Asset Writedowns and Impairment (2016 - 2025)
Perspective Therapeutics recorded quarterly Asset Writedowns and Impairment of $10.0 million in Q4 2025, up 17141.38% quarter-over-quarter from $58000.0 in Q4 2024, and up 17141.38% year-over-year from N/an in Q4 2024.
Perspective Therapeutics' Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $10.0 million for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 17141.38% year-over-year to $10.0 million; the TTM figure through Dec 2025 stood at $10.3 million (up 1627.85% YoY), while the FY2025 annual figure was $10.0 million, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at $10.0 million for Q4 2025 at Perspective Therapeutics, up from $58000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $10.0 million in Q4 2025 to a low of -$58000.0 in Q3 2024.
- A 3-year average of $2.1 million and a median of $298000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Across the five-year window, Asset Writedowns and Impairment plunged 119.46% in 2024 and surged 17141.38% in 2025, its largest moves.
- Perspective Therapeutics' Asset Writedowns and Impairment stood at $298000.0 in 2023, then slumped by 80.54% to $58000.0 in 2024, then soared by 17141.38% to $10.0 million in 2025.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $10.0 million, $58000.0, and -$58000.0 for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 58,000.00 |
| Dec 31, 2024 | 58,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Sep 30, 2024 | -58,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Dec 31, 2023 | 298,000.00 |
| Sep 30, 2023 | 298,000.00 |
| Sep 30, 2023 | 298,000.00 |
| Jun 30, 2017 | -4,000.00 |
| Jun 30, 2017 | -4,000.00 |
| Mar 31, 2016 | 72,000.00 |
| Mar 31, 2016 | 72,000.00 |